生物製药辅料市场规模、份额及成长分析（按产品、功能、应用、最终用户和地区）- 产业预测 2025-2032

2023 年全球生物製药辅料市场规模价值 23 亿美元，预计将从 2024 年的 24.3 亿美元成长到 2032 年的 37.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.6%。

截至 2023 年 10 月，全球生物製药辅料市场呈现稳步上升趋势，这得益于对生物製药的需求不断增加、向个人化医疗的转变以及生物技术和药物输送系统的创新。癌症和自体免疫疾病等慢性疾病的发生率日益上升，导致人们越来越需要标靶治疗，以减少副作用并改善患者的治疗效果。此外，与传统的小分子药物相比，生物製药的使用趋势明显增多，再加上生物技术的进步，推动了对专用辅料的需求，以配合这些创新治疗方法。然而，市场面临着诸如复杂的法规环境、先进製造要求导致的高营运成本以及与传统辅料相比生物製药辅料的价格较高等挑战，这些可能会阻碍其更广泛的应用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

生物製药辅料市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 碳水化合物
  • 葡萄糖
  • 淀粉
  • 蔗糖
• 多元醇
  • 甘露醇
  • 山梨醇
• 增溶剂和界面活性剂/乳化剂
  • 酯
  • 三酸甘油酯
• 特殊添加物

生物製药辅料市场规模（按功能和复合年增长率） (2025-2032)

• 市场概况
• 黏合剂
• 涂层
• 崩坏
• 润滑剂及润滑剂
• 药用填充剂
• 防腐剂

生物製药辅料市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概况
• 先进的传动系统
• 口服
• 肠外
• 外用

生物製药辅料市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 契约製造组织
• 製药和生物技术公司

生物製药辅料市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Merck KGaA（Germany）
• BASF SE（Germany）
• Evonik Industries AG（Germany）
• Roquette Freres（France）
• Colorcon, Inc.（USA）
• DFE Pharma（Germany）
• Avantor, Inc.（USA）
• Kerry Group plc（Ireland）
• Associated British Foods plc（UK）
• Wacker Chemie AG（Germany）
• Lubrizol Corporation（USA）
• J. Rettenmaier & Sohne GmbH+Co KG（Germany）
• SPI Pharma（USA）
• Fuji Chemical Industries Co., Ltd.（Japan）
• Meggle GmbH & Co. KG（Germany）
• Beneo GmbH（Germany）

结论和建议

Global Biopharmaceuticals Excipients Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.43 billion in 2024 to USD 3.76 billion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

As of October 2023, the global biopharmaceutical excipients market is on a steady upward trajectory, fueled by rising demand for biopharmaceutical drugs, a shift towards personalized medicine, and innovations in biotechnology and drug delivery systems. The increasing prevalence of chronic conditions like cancer and autoimmune disorders has heightened the need for targeted therapies, enhancing patient outcomes with fewer side effects. Furthermore, there is a notable preference for biologics over traditional small-molecule drugs, coupled with ongoing biotechnological advancements that drive the demand for specialized excipients tailored for these innovative therapies. However, the market faces challenges including a complex regulatory environment, high operational costs due to advanced manufacturing requirements, and the elevated price of biopharmaceutical excipients compared to their conventional counterparts, potentially hindering broader adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceuticals Excipients Market Segmental Analysis

Global Biopharmaceuticals Excipients Market is segmented by Product, Function, Application, End User and region. Based on Product, the market is segmented into Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers and Specialty Excipients. Based on Function, the market is segmented into Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers and Preservatives. Based on Application, the market is segmented into Advanced Delivery System, Oral, Parenteral and Topical. Based on End User, the market is segmented into Contract Manufacturing Organizations and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceuticals Excipients Market

The global biopharmaceutical excipients market is being significantly driven by the escalating demand for biopharmaceuticals, primarily fueled by the rising incidence of chronic diseases and an aging population. As more individuals seek effective therapeutic solutions, the preference for biologics has intensified due to their targeted approach and enhanced efficacy. This shift necessitates the incorporation of specialized excipients that improve drug attributes such as stability, solubility, and delivery mechanisms. Consequently, the continuous innovation and adaptation of excipients tailored for biopharmaceutical applications are vital in meeting the evolving requirements of the pharmaceutical industry, thereby fostering market growth.

Restraints in the Global Biopharmaceuticals Excipients Market

The global biopharmaceutical excipients market faces significant challenges due to a complex regulatory landscape. The stringent and intricate approval processes for biopharmaceutical drugs require extensive testing and validation of excipients utilized in biologic formulations. This complexity compels excipient manufacturers to navigate a multitude of regulatory standards, which can be time-consuming and resource-intensive. As a result, these regulatory hurdles may impede the growth and expansion of the market, making it difficult for manufacturers to introduce new products and adapt to evolving compliance demands. Consequently, the intricate nature of regulatory requirements presents a substantial restraint on the biopharmaceutical excipients market.

Market Trends of the Global Biopharmaceuticals Excipients Market

The global biopharmaceuticals excipients market is witnessing a significant trend driven by the increasing demand for specialty and functional excipients. As biologic drugs evolve and expand in complexity, the need for excipients that cater to specific formulation requirements has surged. These specialty excipients, designed for functionalities such as protein stabilization, controlled drug release, and enhanced solubility, are gaining traction among manufacturers striving to optimize therapeutic efficacy and patient outcomes. This shift not only underscores the pivotal role of excipients in drug development but also reflects the biopharmaceutical industry's commitment to innovation and precision in delivering advanced healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biopharmaceuticals Excipients Market Size by Product & CAGR (2025-2032)

• Market Overview
• Carbohydrates
  • Dextrose
  • Starch
  • Sucrose
• Polyols
  • Mannitol
  • Sorbitol
• Solubilizers & Surfactants/Emulsifiers
  • Esters
  • Triglycerides
• Specialty Excipients

Global Biopharmaceuticals Excipients Market Size by Function & CAGR (2025-2032)

• Market Overview
• Binders
• Coatings
• Disintegrants
• Lubricants & glidants
• Pharmaceutical Fillers
• Preservatives

Global Biopharmaceuticals Excipients Market Size by Application & CAGR (2025-2032)

• Market Overview
• Advanced Delivery System
• Oral
• Parenteral
• Topical

Global Biopharmaceuticals Excipients Market Size by End User & CAGR (2025-2032)

• Market Overview
• Contract Manufacturing Organizations
• Pharmaceutical & Biotechnology Companies

Global Biopharmaceuticals Excipients Market Size & CAGR (2025-2032)

• North America (Product, Function, Application, End User)
  • US
  • Canada
• Europe (Product, Function, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Function, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Function, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Function, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lubrizol Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J. Rettenmaier & Sohne GmbH + Co KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPI Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industries Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meggle GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beneo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations